Results 131 to 140 of about 33,432 (282)

Treatment of patients with prolactinomas [PDF]

, 1978
Fahlbusch, R., Landgraf, R., Pickardt, C. R., Rjosk, H. K., Scriba, Peter Christian, Werder, Klaus von   +5 more
core   +1 more source

Surgical Management of Gestational Gigantomastia: A Case Report Highlighting Therapeutic Intervention

Plastic and Reconstructive Surgery, Global Open
Summary:. Gigantomastia is an exceedingly rare condition characterized by extraordinary growth of breasts during pregnancy, and its underlying etiology remains elusive.
Misha A. Lemma, MD, Yisihak S. Debodina, MD, Martha F. Gebremedhin, MD, Meki K. Aman, MD, Don Eliseo III Lucero-Prisno, MD, MSc, PhD   +4 more
doaj   +1 more source

The effects of vaginal bromocriptine and dienogest on women with adenomyosis: a clinical study

Middle East Fertility Society Journal
Objective Adenomyosis occurs when endometrial glands and stroma develop in the myometrium, leading to symptoms such as pelvic pain and heavy menstrual bleeding. Method This randomized, double-blinded, controlled trial study was conducted on patients with
Parvane Bahoorzahi, Soheila Aminimoghaddam, Roya Derakhshan, Neda Hashemi, Samaneh Rokhgireh   +4 more
doaj   +1 more source

Hypersscretion of ACTH growth hormone and prolactin in a patient with pituitary adenoma [PDF]

, 1978
Fink, R., Müller, O. A., Scriba, Peter Christian, Werder, Klaus von   +3 more
core   +1 more source

Anti-prolactin autoantibody is a new cause of hyperprolactinemia in which bromocriptine therapy is not required

, 1997
Naoki Hattori, Chiyoko Inagaki
openalex   +1 more source

INVOLVEMENT OF THE ADRENAL GLANDS IN THE HYPOTENSIVE RESPONSE TO BROMOCRIPTINE IN SPONTANEOUSLY HYPERTENSIVE RATS [PDF]

, 1981
T C Hamilton
openalex   +1 more source

Prolactinomas: evolution after menopause

Archives of Endocrinology and Metabolism
Objetive The aim was to assess the evolution of tumor size and prolactin (PRL) levels in patients with micro and macroprolactinomas diagnosed and treated with dopamine agonists during fertile age, and the effects of suspension of drugs after menopause ...
Maria Susana Mallea-Gil, Marcos Manavela, Analia Alfieri, Maria Carolina Ballarino, Alberto Chervin, Karina Danilowicz, Sabrina Diez, Patricia Fainstein Day, Natalia García-Basavilbaso, Mariela Glerean, Mirtha Guitelman, Débora Katz, Monica Graciela Loto, Marcela Martinez, Karina Miragaya, Daniel Moncet, Amelia Susana Rogozinski, Marisa Servidio, Graciela Stalldecker, Marcelo Vitale, Laura Boero   +20 more
doaj   +1 more source

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

Diabetes, Metabolic Syndrome and Obesity, 2010
Michael A Via1, Himani Chandra2, Takako Araki1, Matthew V Potenza3, Maria Skamagas41Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, New York, NY, USA; 2Division of Endocrinology, Diabetes and ...
Via MA
doaj  

FORMULATION AND INVITRO EVALUATION OF BROMOCRIPTINE MESYLATE NON EFFERVESCENT FLOATING TABLETS

, 2018
K. Kishore Pasupuleti Himabindu
openalex   +1 more source

Low-dose bromocriptine in Parkinson's disease. [PDF]

, 1985
I Pearce, John Pearce
openalex   +1 more source